Live: Skype_ Chat +15075562445 (US) sales@htfmarketintelligence.com
Gamma Aminobutyric Acid Market

Gamma Aminobutyric Acid Market - Global Industry Size & Growth Analysis 2019-2031

Global Gamma Aminobutyric Acid Market is segmented by Application (Anxiety treatment, Sleep aids, Supplements, Pharmaceuticals) , Type (Natural, Synthetic, Pharmaceutical grade, Nutraceuticals, Food-grade) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

Pricing
5400
3400
1800

INDUSTRY OVERVIEW

The Gamma Aminobutyric Acid is Growing at 8% and is expected to reach 3 Billion by 2031.  Below mentioned are some of the dynamics shaping the Gamma Aminobutyric Acid .

Gamma Aminobutyric Acid Market Size in (USD Billion) CAGR Growth Rate 8%

Study Period 2019-2031
Market Size (2023): 1.5 Billion
Market Size (2031): 3 Billion
CAGR (2023 - 2031): 8%
www.www.htfmarketinsights.com

Gamma-Aminobutyric acid (GABA) are the inhibitory neurotransmitter that found in the central nervous system of mammals. These neurotransmitter used to reduce the activity of neurons to which it binds, thus used to control fear and anxiety when neuron are over excited. Gamma-Aminobutyric acid market is expected to mark significant growth over forecasted period owing to increasing consumers spending on treatment of neurological disorders and mental disorders. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the healthcare sector.__
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report

Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
  • Rapid Applications For Relieving Injuries And Decreasing Body Fat.

Market Restraints:

Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
  • Market Competition
  • Regulation

Trends in the Market:

Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
  • Increase demand of Gamma Aminobutyric Acid at Asia-Pacific regions.
Market Opportunities:

These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.

  • Rapid Applications For Relieving Injuries And Decreasing Body Fat.
Check Out Prices
Get Price


Regulation Shaping the Healthcare Industry

The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.

Major Regulatory Bodies Worldwide

1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.
2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization


SWOT Analysis in the Healthcare Industry

SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.

•    Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
•    Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
•    Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
•    Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.

Market Segmentation

Segmentation by Type


  • Natural
  • Synthetic
  • Pharmaceutical grade
  • Nutraceuticals

Gamma Aminobutyric Acid Market Segmentation by Type

www.htfmarketinsights.com


Segmentation by Application


  • Anxiety treatment
  • Sleep aids
  • Supplements
  • Pharmaceuticals

Gamma Aminobutyric Acid Market Segmentation by Application

www.htfmarketinsights.com

Regional Outlook

The currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, including 

Regions
  • North America
  • LATAM
  • West Europe
  • Central & Eastern Europe
  • Northern Europe
  • Southern Europe
  • East Asia
  • Southeast Asia
  • South Asia
  • Central Asia
  • Oceania
  • MEA



The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.

  • AstraZeneca (United Kingdom)
  • Athena Drug Delivery Solutions (India)
  • Biocodex (France)
  • Elan Corporation (Ireland)
  • Eli Lilly & Company (United States)
  • H.LundBeck (Denmark)
  • GlaxoSmithKline (United Kingdom)
  • NovaDel Pharma (United States)
  • Novartis (Switzerland)

Gamma Aminobutyric Acid Market Segmentation by Players

www.htfmarketinsights.com

Primary and Secondary Research

Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.
Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.

Report Infographics

Report Features

Details

Base Year

2023

Based Year Market Size (2023)

1.5 Billion

Historical Period

2019 to 2023

CAGR (2023 to 2031)

8%

Forecast Period

2023 to 2031

Forecasted Period Market Size (2031)

3 Billion

Scope of the Report

Natural, Synthetic, Pharmaceutical grade, Nutraceuticals, Anxiety treatment, Sleep aids, Supplements, Pharmaceuticals. Sales Channel

Regions Covered

North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

Companies Covered

AstraZeneca (United Kingdom), Athena Drug Delivery Solutions (India), Biocodex (France), Elan Corporation (Ireland), Eli Lilly & Company (United States), H.LundBeck (Denmark), GlaxoSmithKline (United Kingdom), NovaDel Pharma (United States), Novartis (Switzerland)

Customization Scope

15% Free Customization (For EG)

Delivery Format

PDF and Excel through Email

Gamma Aminobutyric Acid - Table of Contents

Chapter 1: Market Preface
  • 1.1 Global Gamma Aminobutyric Acid Market Landscape
  • 1.2 Scope of the Study
  • 1.3 Relevant Findings & Stakeholder Advantages

Chapter 2: Strategic Overview
  • 2.1 Global Gamma Aminobutyric Acid Market Outlook
  • 2.2 Total Addressable Market versus Serviceable Market
  • 2.3 Market Rivalry Projection

Chapter 3 : Global Gamma Aminobutyric Acid Market Business Environment & Changing Dynamics
  • 3.1 Growth Drivers
    • 3.1.1 Rapid Applications for Relieving Injuries and Decreasing Body Fat.
  • 3.2 Available Opportunities
    • 3.2.1 Rapid Applications for Relieving Injuries and Decreasing Body Fat.
    • 3.2.2 Increased Funding by Governments and Private Organizations.
  • 3.3 Influencing Trends
    • 3.3.1 Increase demand of Gamma Aminobutyric Acid at Asia-Pacific regions.
    • 3.3.2 Value Oriented Consumers
  • 3.4 Challenges
    • 3.4.1 Market competition
    • 3.4.2 Regulation
    • 3.4.3 Quality control
  • 3.5 Regional Dynamics

Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Gamma Aminobutyric Acid Industry Factors Assessment
  • 4.1 Current Scenario
  • 4.2 PEST Analysis
  • 4.3 Business Environment - PORTER 5-Forces Analysis
    • 4.3.1 Supplier Leverage
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of Substitutes
    • 4.3.4 Threat from New Entrant
    • 4.3.5 Market Competition Level
  • 4.4 Roadmap of Gamma Aminobutyric Acid Market
  • 4.5 Impact of Macro-Economic Factors
  • 4.6 Market Entry Strategies
  • 4.7 Political and Regulatory Landscape
  • 4.8 Supply Chain Analysis


Chapter 5: Gamma Aminobutyric Acid : Competition Benchmarking & Performance Evaluation
  • 5.1 Global Gamma Aminobutyric Acid Market Concentration Ratio
    • 5.1.1 CR4, CR8 and HH Index
    • 5.1.2 % Market Share - Top 3
    • 5.1.3 Market Holding by Top 5
  • 5.2 Market Position of Manufacturers by Gamma Aminobutyric Acid Revenue 2023
  • 5.3 Global Gamma Aminobutyric Acid Sales Volume by Manufacturers (2023)
  • 5.4 BCG Matrix
  • 5.4 Market Entropy
  • 5.5 5C’s Analysis
  • 5.6 Ansoff Matrix
Chapter 6: Global Gamma Aminobutyric Acid Market: Company Profiles
  • 6.1 AstraZeneca (United Kingdom)
    • 6.1.1 AstraZeneca (United Kingdom) Company Overview
    • 6.1.2 AstraZeneca (United Kingdom) Product/Service Portfolio & Specifications
    • 6.1.3 AstraZeneca (United Kingdom) Key Financial Metrics
    • 6.1.4 AstraZeneca (United Kingdom) SWOT Analysis
    • 6.1.5 AstraZeneca (United Kingdom) Development Activities
  • 6.2 Athena Drug Delivery Solutions (India)
  • 6.3 Biocodex (France)
  • 6.4 Elan Corporation (Ireland)
  • 6.5 Eli Lilly & Company (United States)
  • 6.6 H.LundBeck (Denmark)
  • 6.7 GlaxoSmithKline (United Kingdom)
  • 6.8 NovaDel Pharma (United States)
  • 6.9 Novartis (Switzerland)
  • 6.10 OVATION Pharmaceuticals (United States)

To View a Complete List of Players? Inquiry Now
Sectional Purchase

Chapter 7 : Global Gamma Aminobutyric Acid by Type & Application (2019-2031)
  • 7.1 Global Gamma Aminobutyric Acid Market Revenue Analysis (USD Million) by Type (2019-2023)
    • 7.1.1 Natural
    • 7.1.2 Synthetic
    • 7.1.3 Pharmaceutical Grade
    • 7.1.4 Nutraceuticals
    • 7.1.5 Food-grade
  • 7.2 Global Gamma Aminobutyric Acid Market Revenue Analysis (USD Million) by Application (2019-2023)
    • 7.2.1 Anxiety Treatment
    • 7.2.2 Sleep Aids
    • 7.2.3 Supplements
    • 7.2.4 Pharmaceuticals
  • 7.3 Global Gamma Aminobutyric Acid Market Revenue Analysis (USD Million) by Type (2023-2031)
  • 7.4 Global Gamma Aminobutyric Acid Market Revenue Analysis (USD Million) by Application (2023-2031)

Chapter 8 : North America Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 8.1 North America Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.1.1 United States
    • 8.1.2 Canada
  • 8.2 North America Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.2.1 Natural
    • 8.2.2 Synthetic
    • 8.2.3 Pharmaceutical Grade
    • 8.2.4 Nutraceuticals
    • 8.2.5 Food-grade
  • 8.3 North America Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.3.1 Anxiety Treatment
    • 8.3.2 Sleep Aids
    • 8.3.3 Supplements
    • 8.3.4 Pharmaceuticals
  • 8.4 North America Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 8.5 North America Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 8.6 North America Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Looking for Section Purchase? Get Quote Now
Sectional Purchase

Chapter 9 : LATAM Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 9.1 LATAM Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.1.1 Brazil
    • 9.1.2 Argentina
    • 9.1.3 Chile
    • 9.1.4 Mexico
    • 9.1.5 Rest of LATAM
  • 9.2 LATAM Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.2.1 Natural
    • 9.2.2 Synthetic
    • 9.2.3 Pharmaceutical Grade
    • 9.2.4 Nutraceuticals
    • 9.2.5 Food-grade
  • 9.3 LATAM Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.3.1 Anxiety Treatment
    • 9.3.2 Sleep Aids
    • 9.3.3 Supplements
    • 9.3.4 Pharmaceuticals
  • 9.4 LATAM Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 9.5 LATAM Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 9.6 LATAM Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 10 : West Europe Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 10.1 West Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.1.1 Germany
    • 10.1.2 France
    • 10.1.3 Benelux
    • 10.1.4 Switzerland
    • 10.1.5 Rest of West Europe
  • 10.2 West Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.2.1 Natural
    • 10.2.2 Synthetic
    • 10.2.3 Pharmaceutical Grade
    • 10.2.4 Nutraceuticals
    • 10.2.5 Food-grade
  • 10.3 West Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.3.1 Anxiety Treatment
    • 10.3.2 Sleep Aids
    • 10.3.3 Supplements
    • 10.3.4 Pharmaceuticals
  • 10.4 West Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 10.5 West Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 10.6 West Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 11 : Central & Eastern Europe Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 11.1 Central & Eastern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.1.1 Bulgaria
    • 11.1.2 Poland
    • 11.1.3 Hungary
    • 11.1.4 Romania
    • 11.1.5 Rest of CEE
  • 11.2 Central & Eastern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.2.1 Natural
    • 11.2.2 Synthetic
    • 11.2.3 Pharmaceutical Grade
    • 11.2.4 Nutraceuticals
    • 11.2.5 Food-grade
  • 11.3 Central & Eastern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.3.1 Anxiety Treatment
    • 11.3.2 Sleep Aids
    • 11.3.3 Supplements
    • 11.3.4 Pharmaceuticals
  • 11.4 Central & Eastern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 11.5 Central & Eastern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 11.6 Central & Eastern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 12 : Northern Europe Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 12.1 Northern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.1.1 The United Kingdom
    • 12.1.2 Sweden
    • 12.1.3 Norway
    • 12.1.4 Baltics
    • 12.1.5 Ireland
    • 12.1.6 Rest of Northern Europe
  • 12.2 Northern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.2.1 Natural
    • 12.2.2 Synthetic
    • 12.2.3 Pharmaceutical Grade
    • 12.2.4 Nutraceuticals
    • 12.2.5 Food-grade
  • 12.3 Northern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.3.1 Anxiety Treatment
    • 12.3.2 Sleep Aids
    • 12.3.3 Supplements
    • 12.3.4 Pharmaceuticals
  • 12.4 Northern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 12.5 Northern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 12.6 Northern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 13 : Southern Europe Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 13.1 Southern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.1.1 Spain
    • 13.1.2 Italy
    • 13.1.3 Portugal
    • 13.1.4 Greece
    • 13.1.5 Rest of Southern Europe
  • 13.2 Southern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.2.1 Natural
    • 13.2.2 Synthetic
    • 13.2.3 Pharmaceutical Grade
    • 13.2.4 Nutraceuticals
    • 13.2.5 Food-grade
  • 13.3 Southern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.3.1 Anxiety Treatment
    • 13.3.2 Sleep Aids
    • 13.3.3 Supplements
    • 13.3.4 Pharmaceuticals
  • 13.4 Southern Europe Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 13.5 Southern Europe Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 13.6 Southern Europe Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 14 : East Asia Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 14.1 East Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.1.1 China
    • 14.1.2 Japan
    • 14.1.3 South Korea
    • 14.1.4 Taiwan
    • 14.1.5 Others
  • 14.2 East Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.2.1 Natural
    • 14.2.2 Synthetic
    • 14.2.3 Pharmaceutical Grade
    • 14.2.4 Nutraceuticals
    • 14.2.5 Food-grade
  • 14.3 East Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.3.1 Anxiety Treatment
    • 14.3.2 Sleep Aids
    • 14.3.3 Supplements
    • 14.3.4 Pharmaceuticals
  • 14.4 East Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 14.5 East Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 14.6 East Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 15 : Southeast Asia Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 15.1 Southeast Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.1.1 Vietnam
    • 15.1.2 Singapore
    • 15.1.3 Thailand
    • 15.1.4 Malaysia
    • 15.1.5 Indonesia
    • 15.1.6 Philippines
    • 15.1.7 Rest of SEA Countries
  • 15.2 Southeast Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.2.1 Natural
    • 15.2.2 Synthetic
    • 15.2.3 Pharmaceutical Grade
    • 15.2.4 Nutraceuticals
    • 15.2.5 Food-grade
  • 15.3 Southeast Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.3.1 Anxiety Treatment
    • 15.3.2 Sleep Aids
    • 15.3.3 Supplements
    • 15.3.4 Pharmaceuticals
  • 15.4 Southeast Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 15.5 Southeast Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 15.6 Southeast Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 16 : South Asia Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 16.1 South Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.1.1 India
    • 16.1.2 Bangladesh
    • 16.1.3 Others
  • 16.2 South Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.2.1 Natural
    • 16.2.2 Synthetic
    • 16.2.3 Pharmaceutical Grade
    • 16.2.4 Nutraceuticals
    • 16.2.5 Food-grade
  • 16.3 South Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.3.1 Anxiety Treatment
    • 16.3.2 Sleep Aids
    • 16.3.3 Supplements
    • 16.3.4 Pharmaceuticals
  • 16.4 South Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 16.5 South Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 16.6 South Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 17 : Central Asia Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 17.1 Central Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.1.1 Kazakhstan
    • 17.1.2 Tajikistan
    • 17.1.3 Others
  • 17.2 Central Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.2.1 Natural
    • 17.2.2 Synthetic
    • 17.2.3 Pharmaceutical Grade
    • 17.2.4 Nutraceuticals
    • 17.2.5 Food-grade
  • 17.3 Central Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.3.1 Anxiety Treatment
    • 17.3.2 Sleep Aids
    • 17.3.3 Supplements
    • 17.3.4 Pharmaceuticals
  • 17.4 Central Asia Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 17.5 Central Asia Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 17.6 Central Asia Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 18 : Oceania Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 18.1 Oceania Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.1.1 Australia
    • 18.1.2 New Zealand
    • 18.1.3 Others
  • 18.2 Oceania Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.2.1 Natural
    • 18.2.2 Synthetic
    • 18.2.3 Pharmaceutical Grade
    • 18.2.4 Nutraceuticals
    • 18.2.5 Food-grade
  • 18.3 Oceania Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.3.1 Anxiety Treatment
    • 18.3.2 Sleep Aids
    • 18.3.3 Supplements
    • 18.3.4 Pharmaceuticals
  • 18.4 Oceania Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 18.5 Oceania Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 18.6 Oceania Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 19 : MEA Gamma Aminobutyric Acid Market Breakdown by Country, Type & Application
  • 19.1 MEA Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.1.1 Turkey
    • 19.1.2 South Africa
    • 19.1.3 Egypt
    • 19.1.4 UAE
    • 19.1.5 Saudi Arabia
    • 19.1.6 Israel
    • 19.1.7 Rest of MEA
  • 19.2 MEA Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.2.1 Natural
    • 19.2.2 Synthetic
    • 19.2.3 Pharmaceutical Grade
    • 19.2.4 Nutraceuticals
    • 19.2.5 Food-grade
  • 19.3 MEA Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.3.1 Anxiety Treatment
    • 19.3.2 Sleep Aids
    • 19.3.3 Supplements
    • 19.3.4 Pharmaceuticals
  • 19.4 MEA Gamma Aminobutyric Acid Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 19.5 MEA Gamma Aminobutyric Acid Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 19.6 MEA Gamma Aminobutyric Acid Market by Application (USD Million) & Sales Volume (Units) [2024-2031]

Chapter 20: Research Findings & Conclusion
  • 20.1 Key Findings
  • 20.2 Conclusion

Chapter 21: Methodology and Data Source
  • 21.1 Research Methodology & Approach
    • 21.1.1 Research Program/Design
    • 21.1.2 Market Size Estimation
    • 21.1.3 Market Breakdown and Data Triangulation
  • 21.2 Data Source
    • 21.2.1 Secondary Sources
    • 21.2.2 Primary Sources

Chapter 22: Appendix & Disclaimer
  • 22.1 Acronyms & bibliography
  • 22.2 Disclaimer

Frequently Asked Questions (FAQ):

The Gamma Aminobutyric Acid market may reach an estimated size of 3 Billion by 2031.

The Gamma Aminobutyric Acid Market is estimated to grow at a CAGR of 8%, currently pegged at 1.5 Billion.

Increase Demand Of Gamma Aminobutyric Acid At Asia-Pacific Regions., Value Oriented Consumers are seen to make big Impact on Gamma Aminobutyric Acid Market Growth.

The leaders in the Global Gamma Aminobutyric Acid Market such as AstraZeneca (United Kingdom), Athena Drug Delivery Solutions (India), Biocodex (France), Elan Corporation (Ireland), Eli Lilly & Company (United States), H.LundBeck (Denmark), GlaxoSmithKline (United Kingdom), NovaDel Pharma (United States), Novartis (Switzerland), OVATION Pharmaceuticals (United States) are targeting innovative and differentiated growth drivers some of them are Rapid Applications For Relieving Injuries And Decreasing Body Fat., Increased Funding By Governments And Private Organizations.

Business transformation in Gamma Aminobutyric Acid Market has taken hold due to the confluence of several important triggers, some of them are Market Competition, Regulation, Quality Control.

Some of the opportunities that Analyst at HTF MI have identified in Gamma Aminobutyric Acid Market are:
  • Rapid Applications For Relieving Injuries And Decreasing Body Fat.
  • Increased Funding By Governments And Private Organizations.

AstraZeneca (United Kingdom), Athena Drug Delivery Solutions (India), Biocodex (France), Elan Corporation (Ireland), Eli Lilly & Company (United States), H.LundBeck (Denmark), GlaxoSmithKline (United Kingdom), NovaDel Pharma (United States), Novartis (Switzerland), OVATION Pharmaceuticals (United States) are the major operating companies profiled in Gamma Aminobutyric Acid market study.

Research paper of Global Gamma Aminobutyric Acid Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Anxiety treatment, Sleep aids, Supplements, Pharmaceuticals.

The Global Gamma Aminobutyric Acid Market Study is segmented by Natural, Synthetic, Pharmaceutical grade, Nutraceuticals, Food-grade.

The Global Gamma Aminobutyric Acid Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

Historical Year: 2019 - 2023; Base year: 2023; Forecast period: 2025 to 2031

Gamma-Aminobutyric acid (GABA) are the inhibitory neurotransmitter that found in the central nervous system of mammals. These neurotransmitter used to reduce the activity of neurons to which it binds, thus used to control fear and anxiety when neuron are over excited. Gamma-Aminobutyric acid market is expected to mark significant growth over forecasted period owing to increasing consumers spending on treatment of neurological disorders and mental disorders. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the healthcare sector.__
HTF MI Logo

Contact Info

304 B, Town Square, New Airport Road, Viman Nagar, Pune - 411014 sales@htfmarketintelligence.com +15075562445 (US)

Explore

Home About Us Reports Category Contact Us FAQs

Policy

Terms & Conditions Privacy Policy
HTF Market Intelligence, All right reserved 2025.
Designed By S3World
-->